Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanyang Yixinkang Capsule for Coronary Artery Disease Angina (Yang Deficiency and Blood Stasis Pattern)
CTR20132396Phase 2Completed
- Sponsor
- Jilin Academy of Chinese Medicine Sciences
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Sanyang Yixinkang in coronary arteriosclerosis, angina pectoris, sponsored by Jilin Academy of Chinese Medicine Sciences. Started Jan 2014; status: completed.
02
Drugs
Sanyang Yixinkang
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on CTR20132396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132396.